Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no study data or essential content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange Detected- The page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page now displays a glossary and updates metadata labels to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', with minor wording changes such as 'No FEAR Act Data'.SummaryDifference0.2%

- Check46 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no study content or functionality were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedLocations were reorganized under a single Locations section, consolidating state entries (Colorado, Illinois, Maryland, Massachusetts, New York, Texas, Utah) and updating the page revision from v3.3.2 to v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference0.9%

- Check95 days agoChange DetectedPublications section now notes that PubMed entries are auto-filled and may not all relate to the study; revision numbers updated to v3.3.2 and v3.2.0.SummaryDifference0.1%

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.